The hydrophobic tail of a pH-sensitive cationic lipid influences siRNA transfection activity and toxicity in human NK cell lines

被引:30
作者
Nakamura, Takashi [1 ]
Nakade, Taisei [1 ]
Yamada, Koharu [1 ]
Sato, Yusuke [1 ]
Harashima, Hideyoshi [1 ]
机构
[1] Hokkaido Univ, Fac Pharmaceut Sci, Kita Ku, Kita 12,Nishi 6, Sapporo, Hokkaido 0600812, Japan
关键词
Non-viral; Lipid nanoparticle; siRNA; pH-sensitive cationic lipid; NK cell; NK-92; INTRACELLULAR DELIVERY; NANOPARTICLES; CANCER; IMMUNOTHERAPY; DESIGN; NK-92;
D O I
10.1016/j.ijpharm.2021.121140
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The use of natural killer (NK) cells in cell therapy is an attractive next generation strategy for cancer immunotherapy. NK-92 cells (a human NK cell line) have been tested in clinical trial stages, making them an off-theshelf medicine. Controlling gene expression in NK-92 cells by an artificial delivery system is an available for enhancing NK-92 cell therapy. We report here on the development of a siRNA-loaded lipid nanoparticle (LNP) composed of CL1H6 (CL1H6-LNP), an optimized, pH-sensitive cationic lipid, with efficient gene silencing and low cytotoxicity in NK-92 cells. The hydrophilic head group of the lipid molecule used in preparing these particles largely influences the pKa of the final LNP, and lipids with an amino moiety substituted with a methyl group showed a high gene silencing activity. Compared with myristate and palmitate, the hydrophobic tail of oleate had a high gene silencing activity and cell viability. Analyses of intracellular trafficking indicated that the CL1H6-LNP appeared to escape from the endosomes via membrane fusion, without disrupting the membrane. The mechanism of endosomal escape should contribute to our understanding of efficient gene silencing with a low degree of cytotoxicity. These results therefore suggest that a CL1H6-LNP has promise for delivering siRNA to NK-92 cells.
引用
收藏
页数:11
相关论文
共 31 条
[21]   Understanding structure-activity relationships of pH-sensitive cationic lipids facilitates the rational identification of promising lipid nanoparticles for delivering siRNAs in vivo [J].
Sato, Yusuke ;
Hashiba, Kazuki ;
Sasaki, Kosuke ;
Maeki, Masatoshi ;
Tokeshi, Manabu ;
Harashima, Hideyoshi .
JOURNAL OF CONTROLLED RELEASE, 2019, 295 :140-152
[22]   Relationship Between the Physicochemical Properties of Lipid Nanoparticles and the Quality of siRNA Delivery to Liver Cells [J].
Sato, Yusuke ;
Hatakeyama, Hiroto ;
Hyodo, Mamoru ;
Harashima, Hideyoshi .
MOLECULAR THERAPY, 2016, 24 (04) :788-795
[23]   Cytosolic delivery of nucleic acids: The case of ionizable lipid nanoparticles [J].
Schlich, Michele ;
Palomba, Roberto ;
Costabile, Gabriella ;
Mizrahy, Shoshy ;
Pannuzzo, Martina ;
Peer, Dan ;
Decuzzi, Paolo .
BIOENGINEERING & TRANSLATIONAL MEDICINE, 2021, 6 (02)
[24]   Rational design of cationic lipids for siRNA delivery [J].
Semple, Sean C. ;
Akinc, Akin ;
Chen, Jianxin ;
Sandhu, Ammen P. ;
Mui, Barbara L. ;
Cho, Connie K. ;
Sah, Dinah W. Y. ;
Stebbing, Derrick ;
Crosley, Erin J. ;
Yaworski, Ed ;
Hafez, Ismail M. ;
Dorkin, J. Robert ;
Qin, June ;
Lam, Kieu ;
Rajeev, Kallanthottathil G. ;
Wong, Kim F. ;
Jeffs, Lloyd B. ;
Nechev, Lubomir ;
Eisenhardt, Merete L. ;
Jayaraman, Muthusamy ;
Kazem, Mikameh ;
Maier, Martin A. ;
Srinivasulu, Masuna ;
Weinstein, Michael J. ;
Chen, Qingmin ;
Alvarez, Rene ;
Barros, Scott A. ;
De, Soma ;
Klimuk, Sandra K. ;
Borland, Todd ;
Kosovrasti, Verbena ;
Cantley, William L. ;
Tam, Ying K. ;
Manoharan, Muthiah ;
Ciufolini, Marco A. ;
Tracy, Mark A. ;
de Fougerolles, Antonin ;
MacLachlan, Ian ;
Cullis, Pieter R. ;
Madden, Thomas D. ;
Hope, Michael J. .
NATURE BIOTECHNOLOGY, 2010, 28 (02) :172-U18
[25]   Treatment of patients with advanced cancer with the natural killer cell line NK-92 [J].
Tonn, Torsten ;
Schwabe, Dirk ;
Klingemann, Hans G. ;
Becker, Sven ;
Esser, Ruth ;
Koehl, Ulrike ;
Suttorp, Meinolf ;
Seifried, Erhard ;
Ottimann, Oliver G. ;
Bug, Gesine .
CYTOTHERAPY, 2013, 15 (12) :1563-1570
[26]   Enhanced Cancer Immunotherapy with Smad3-Silenced NK-92 Cells [J].
Wang, Qing-Ming ;
Tang, Patrick Ming-Kuen ;
Lian, Guang-Yu ;
Li, Chunjie ;
Li, Jinhong ;
Huang, Xiao-Ru ;
To, Ka-Fai ;
Lan, Hui-Yao .
CANCER IMMUNOLOGY RESEARCH, 2018, 6 (08) :965-977
[27]   Novel polymerizable surfactants with pH-sensitive amphiphilicity and cell membrane disruption for efficient siRNA delivery [J].
Wang, Xu-Li ;
Ramusovic, Sergej ;
Nguyen, Thanh ;
Lu, Zheng-Rong .
BIOCONJUGATE CHEMISTRY, 2007, 18 (06) :2169-2177
[28]   A lipid nanoparticle for the efficient delivery of siRNA to dendritic cells [J].
Warashina, Shota ;
Nakamura, Takashi ;
Sato, Yusuke ;
Fujiwara, Yuki ;
Hyodo, Mamoru ;
Hatakeyama, Hiroto ;
Harashima, Hideyoshi .
JOURNAL OF CONTROLLED RELEASE, 2016, 225 :183-191
[29]   The global pipeline of cell therapies for cancer [J].
Yu, Jia Xin ;
Hubbard-Lucey, Vanessa M. ;
Tang, Jun .
NATURE REVIEWS DRUG DISCOVERY, 2019, 18 (11) :821-822
[30]   Natural Killer Cells and Current Applications of Chimeric Antigen Receptor-Modified NK-92 Cells in Tumor Immunotherapy [J].
Zhang, Jianguang ;
Zheng, Huifang ;
Diao, Yong .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (02)